Assignee
ASCENTAGE PHARMA SUZHOU CO LTD
CN·34 granted patents·37 pending applications·21 citations·filing 2019–2025
Top patents by PatentIndex Score
71 records- 0194US11850239B2MDM2 inhibitor and a platinum compound for cancer treatmentASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Dec 26, 2023·3 cites·20 claims
- 0290US11452716B2Pharmaceutical composition and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Sep 27, 2022·3 cites·20 claims
- 0389US11312724B2Spirocyclic tetrahydroquinazolinesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Granted Apr 26, 2022·4 cites·14 claims
- 0486US11787814B2Method for preparing 2-indolinospirone compound and intermediate thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Oct 17, 2023·3 cites·16 claims
- 0583US11478469B2Combination product of BCL-2 inhibitor and MDM2 inhibitor and use thereof in the prevention and/or treatment of diseasesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Oct 25, 2022·2 cites·10 claims
- 0679US11691989B2Macrocyclic indoles as Mcl-1 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Jul 4, 2023·3 cites·41 claims
- 0778US12268665B2Combination of immunotherapies with MDM2 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Apr 8, 2025·1 cites·13 claims
- 0878US11395815B2Compound for treating osteoarthritisASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jul 26, 2022·1 cites·14 claims
- 0975US12544370B2Methods for cancer therapyASCENTAGE PHARMA SUZHOU CO LTD·Filed 2023·Granted Feb 10, 2026·0 cites·10 claims
- 1074US2026028346A1Btk degrader and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 1172US11370807B2Process for preparing sulfonamide compoundsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jun 28, 2022·1 cites·11 claims
- 1272US2025333415A1Crystalline forms or amorphous forms of n-(phenyl sulfonyl) benzamide compounds or its salts or solvatesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 1372US2024390401A1Combination of bcl-2/bcl-xl inhibitors and chemotherapeutic agent and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2024·Application pending·0 cites
- 1470US2026028345A1Btk degrader and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 1568US2026053815A1Combination product of a bcl-2/bcl-xl inhibitor and a chemotherapeutic agent and use thereof in the prevention and/or treatment of diseasesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 1667US12083136B2Combination of BCL-2/BCL-XL inhibitors and chemotherapeutic agent and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Sep 10, 2024·0 cites·4 claims
- 1765US2025057834A1Pharmaceutical composition containing alkynyl compound and preparation method and application thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2024·Application pending·0 cites
- 1864US2025281511A1N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 1963US12370197B2Combination product of a Bcl-2/Bcl-xL inhibitor and a chemotherapeutic agent and use thereof in the prevention and/or treatment of diseasesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jul 29, 2025·0 cites·8 claims
- 2063US12233047B2Pharmaceutical combination and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Feb 25, 2025·0 cites·20 claims
- 2163US2025152580A1Methods for treating immune diseasesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 2263US2022193071A1Methods for cancer therapyASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Application pending·0 cites
- 2362US12343352B2N-(phenylsulfonyl)benzamides and related compounds as Bcl-2 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jul 1, 2025·0 cites·12 claims
- 2462US11491167B2Combination product of Bcl-2 inhibitor and chemotherapeutic agent and use thereof in the prevention and/or treatment of diseasesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Nov 8, 2022·0 cites·11 claims
- 2560US2023404998A1Combination Therapies for Treating CancerASCENTAGE PHARMA SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 2660US2025114329A1Methods for treating aml-mrc and mdsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 2759US12358912B2Crystalline forms or amorphous forms of N-(phenyl sulfonyl) benzamide compounds or its salts or solvatesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Granted Jul 15, 2025·0 cites·11 claims
- 2859US12097195B2Pharmaceutical composition containing alkynyl compound and preparation method and application thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Sep 24, 2024·0 cites·18 claims
- 2959US11554127B2Synergistic antitumor effect of Bcl-2 inhibitor combined with rituximab and/or bendamustine or Bcl-2 inhibitor combined with CHOPASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Jan 17, 2023·0 cites·12 claims
- 3059US2025099440A1A pharmaceutical combination and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 3158US2025179073A1Tricyclic heterocycle compounds as iap antagonistsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 3257US2025235426A1Pharmaceutical Combination and Use ThereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2025·Application pending·0 cites
- 3357US2024316051A1A pharmaceutical combination and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 3457US2024366611A1Methods of treating a disease or disorderASCENTAGE PHARMA SUZHOU CO LTD·Filed 2022·Application pending·0 cites
- 3557US2025109134A1Crystalline form or amorphous form of macrocyclic compound or salt or solvate thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2023·Application pending·0 cites
- 3656US2024316069A1Methods of treating multiple sclerosisASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 3756US2023381176A1A pharmaceutical composition and use thereof for treatment of cancerASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 3856US2023398110A1Compositions and methods for treating non-alcoholic steatohepatitisASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 3955US2023149356A1Novel medical use of mdm2 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 4054US12577245B2Sulfonyl benzamide derivatives as Bcl-2 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2022·Granted Mar 17, 2026·0 cites·21 claims
- 4154US12287338B2Method and compositions for predicting anti-cancer efficacy of compounds targeting apoptosis pathwayASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Apr 29, 2025·0 cites·12 claims
- 4254US12221427B2Preparation method of (5-fluoro-2,3-dihydrobenzofuran-4-yl)methanamine or its salt, and intermediates thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Granted Feb 11, 2025·0 cites·11 claims
- 4354US2023301989A1Compositions and methods for treating systemic lupus erythematosusASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 4454US2023078120A1Methods for Treating Coronavirus InfectionsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 4554US2022296557A1Combinations of bcl-2/bcl-xl inhibitors and related usesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 4653US12514863B2Pharmaceutical combination and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jan 6, 2026·0 cites·6 claims
- 4753US2021275522A1Pharmaceutical compositions and use thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Application pending·0 cites
- 4853US2024016747A1Solid dispersion, pharmaceutical preparations, preparation method, and application thereofASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Application pending·0 cites
- 4952US12194024B2Pharmaceutical composition of MDM2 inhibitor and use thereof for preventing and/or treating diseaseASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jan 14, 2025·0 cites·5 claims
- 5052US12186304B2Method for treating cancer by combination of IAP inhibitor and modulator of immune checkpoint moleculeASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Jan 7, 2025·0 cites·22 claims
Showing the top 50 of 71 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when ASCENTAGE PHARMA SUZHOU CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →